Development of Pasteurella multocida-loaded microparticles for hemorrhagic septicemia vaccine

References

• Hodgson JC, Finucane A, Dagleish MP, et al. Efficacy of vaccination of calves against hemorrhagic septicemia with a live aroA derivative of Pasteurella multocida B:2 by two different routes of administration. Infect Immun 2005;73:1475–81
   PubMed Web of Science ®Google Scholar
• Shah NH, de Graaf FK. Protection against haemorrhagic septicaemia induced by vaccination of buffalo calves with an improved oil adjuvant vaccine. FEMS Microbiol Lett 1997;155:203–7
   PubMed Web of Science ®Google Scholar
• Verma R, Jaiswal TN. Protection, humoral and cell-mediated immune responses in calves immunized with multiple emulsion haemorrhagic septicaemia vaccine. Vaccine 1997;15:1254–60
   PubMed Web of Science ®Google Scholar
• Hori Y, Winans AM, Irvine DJ. Modular injectable matrices based on alginate solution/microsphere mixtures that gel in situ and co-deliver immunomodulatory factors. Acta Biomater 2009;5:969–82
   PubMed Web of Science ®Google Scholar
• Bowey K, Swift BE, Flynn LE, Neufeld RJ. Characterization of biologically active insulin-loaded alginate microparticles prepared by spray drying. Drug Dev Ind Pharm 2013;39:457–65
   PubMed Web of Science ®Google Scholar
• El Maghraby GM, Elzayat EM, Alanazi FK. Development of modified in situ gelling oral liquid sustained release formulation of dextromethorphan. Drug Dev Ind Pharm 2012;38:971–8
   PubMed Web of Science ®Google Scholar
• Tonnesen HH, Karlsen J. Alginate in drug delivery systems. Drug Dev Ind Pharm 2002;28:621–30
   PubMed Web of Science ®Google Scholar
• Bowersock TL, HogenEsch H, Suckow M, et al. Oral vaccination with alginate microsphere systems. J Control Release 1996;39:209–20
   Web of Science ®Google Scholar
• de Vos P, Faas MM, Strand B, Calafiore R. Alginate-based microcapsules for immunoisolation of pancreatic islets. Biomaterials 2006;27:5603–17
   PubMed Web of Science ®Google Scholar
• Espevik T, Otterlei M, Skjak-Braek G, et al. The involvement of CD14 in stimulation of cytokine production by uronic acid polymers. Eur J Immunol 1993;23:255–61
   PubMed Web of Science ®Google Scholar
• Kidane A, Guimond P, Ju TR, et al. The efficacy of oral vaccination of mice with alginate encapsulated outer membrane proteins of Pasteurella haemolytica and One-Shot®. Vaccine 2001;19:2637–46
   PubMed Web of Science ®Google Scholar
• Rodrigues AP, Hirsch D, Figueiredo HCP, et al. Production and characterisation of alginate microparticles incorporating Aeromonas hydrophila designed for fish oral vaccination. Process Biochem 2006;41:638–43
   Web of Science ®Google Scholar
• Suckow MA, Jarvinen LZ, HogenEsch H, et al. Immunization of rabbits against a bacterial pathogen with an alginate microparticle vaccine. J Control Release 2002;85:227–35
   PubMed Web of Science ®Google Scholar
• Tiyaboonchai W, Nimtrakul P, Limpeanchob N. Development of Pasteurella multocida loaded alginate based microspheres. Naresuan Univ J 2010;18:19–25
   Google Scholar
• Mc-Neil Watson F, Tscharnuter W, Miller J. A new instrument for the measurement of very small electrophoretic mobilities using phase analysis light scattering (PALS). Colloids Surf A Physicochem Eng Aspect 1998;140:53–7
   Web of Science ®Google Scholar
• ASEAN. ASEAN standard requirements for haemorrhagic septicaemia bacterin for cattle and buffaloes. In: Manual of ASEAN standards for animal vaccines. Livestock publication series no. 2A. 2nd ed. Jakarta, Indonesia: ASEAN Secretariat; 1998:77–8
   Google Scholar
• World Organization for Animal Health (OIE). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. 6th ed. Paris, France: Office International Des Epizooties; 2008
   Google Scholar
• Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Epidemiol 1938;27:493–7
   Google Scholar
• De Temmerman ML, Rejman J, Demeester J, et al. Particulate vaccines: on the quest for optimal delivery and immune response. Drug Discov Today 2011;16:569–82
   PubMed Web of Science ®Google Scholar
• Jiang HL, Park IK, Shin NR, et al. In vitro study of the immune stimulating activity of an athrophic rhinitis vaccine associated to chitosan microspheres. Eur J Pharm Biopharm 2004;58:471–6
   PubMed Web of Science ®Google Scholar
• Katare YK, Muthukumaran T, Panda AK. Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles. Int J Pharm 2005;301:149–60
   PubMed Web of Science ®Google Scholar
• Thomas C, Gupta V, Ahsan F. Particle size influences the immune response produced by hepatitis B vaccine formulated in inhalable particles. Pharm Res 2010;27:905–19
   PubMed Web of Science ®Google Scholar
• Kidane A, Guimond P, Rob Ju TC, et al. Effects of cellulose derivatives and poly(ethylene oxide)-poly(propylene oxide) tri-block copolymers (Pluronic)surfactants) on the properties of alginate based microspheres and their interactions with phagocytic cells. J Control Release 2002;85:181–9
   PubMed Web of Science ®Google Scholar
• Xiang SD, Scholzen A, Minigo G, et al. Pathogen recognition and development of particulate vaccines: does size matter? Methods 2006;40:1–9
   PubMed Web of Science ®Google Scholar
• Alipour S, Montaseri H, Tafaghodi M. Preparation and characterization of biodegradable paclitaxel loaded alginate microparticles for pulmonary delivery. Colloids Surf B Biointerfaces 2010;81:521–9
   PubMed Web of Science ®Google Scholar
• Chretien C, Chaumeil JC. Release of a macromolecular drug from alginate-impregnated microspheres. Int J Pharm 2005;304:18–28
   PubMed Web of Science ®Google Scholar
• O’Hagan DT, Singh M, Ulmer JB. Microparticle-based technologies for vaccines. Methods 2006;40:10–19
   PubMed Web of Science ®Google Scholar
• Wilson-Welder JH, Torres MP, Kipper MJ, et al. Vaccine adjuvants: current challenges and future approaches. J Pharm Sci 2009;98:1278–316
   PubMed Web of Science ®Google Scholar
• Aucouturier J, Dupuis L, Ganne V. Adjuvants designed for veterinary and human vaccines. Vaccine 2001;19:2666–72
   PubMed Web of Science ®Google Scholar
• Muneer R, Hussain M, Zahoor AB. Efficacy of oil based haemorrhagic septicaemia vaccine: a field trial. Int J Agric Biol 2005;7:571–3
   Google Scholar
• Sotoodehnia A, Moazeni G, Ataei S, Omidi B. Study on immunity of an experimental oil adjuvant haemorrhagic septicaemia vaccine in cattle. Arch Razi Inst 2005;59:95–101
   Google Scholar
• Zulfiqar A, Muhammad K, Hussain I, Hameed E. Antibody response of buffaloes to haemorrhagic septicaemia vaccine. Int J Agric Biol 2000;2:183–6
   Google Scholar
• Herath C, Kumar P, Singh M, et al. Experimental iron-inactivated Pasteurella multocida A: 1 vaccine adjuvanted with bacterial DNA is safe and protects chickens from fowl cholera. Vaccine 2010;28:2284–9
   PubMed Web of Science ®Google Scholar